[1]CAI J,ZHAO J,GAO P,et al.Patchouli alcohol inhibits GPBAR1-mediated cell proliferation,apoptosis, migration, and invasion in prostate cancer[J].Transl Androl Urol,2022,11(11):1555-1567.
[2]REBELLO RJ,OING C,KNUDSEN KE,et al.Prostate cancer[J].Nat Rev Dis Primers,2021,7(1):9.
[3]ZOU MZ,LIU WL,LI CX,et al.A multifunctional biomimet-ic nanoplatform for relieving hypoxia to enhance chemother-apy and inhibit the PD-1/PD-L1 axis[J].Small,2018,14(28):e1801120.
[4]王轩,陈钦,尚彦国,等.miR-20a/106b调控NKG2D途径介导儿童型脑干胶质瘤免疫逃逸的实验研究[J].中华神经外科杂志,2021,37(3):298-306.
WANG X,CHEN Q,SHANG YG,et al.An experimental study on the regulation of NKG2D pathway by miR-20a/106b to mediate immune escape in childhood brainstem gliomas[J].Chinese Journal of Neurosurgery,2021,37(3):298-306.
[5]ZHANG P,YANG X,WANG L,et al.Overexpressing miR 335 inhibits DU145 cell proliferation by targeting early growth response 3 in prostate cancer[J].Int J Oncol,2019,54(6):1981-1994.
[6]CAPUTO S,GRIONI M,BRAMBILLASCA CS,et al.Galectin-3 in prostate cancer stem-like cells is immunosuppressive and drives early metastasis[J].Front Immunol,2020,11(1):1820-1836.
[7]彭文,范长玲,张浩.HIF-1α通过调控miR-544对A549肺癌细胞免疫逃逸及NCR1/NKP46通路的影响[J].临床肺科杂志,2020,25(8):1246-1251.
PENG W,FAN CL,ZHANG H.Effects of HIF-1α on immune escape and NCR1/NKP46 pathway in A549 lung cancer cells by regulating miR-544 [J].Journal of Clinical Pulmonology,2020,25(8):1246-1251.
[8]OELSNER S,FRIEDE ME,ZHANG C,et al.Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma[J].Cytotherapy,2017,19(2):235-249.
[9]张萌,颜蕴.6,7,4'-三羟基异黄酮通过上调MICA/B表达抑制宫颈癌免疫逃逸机制研究[J].中国免疫学杂志,2021,37(23):2875-2879.
ZHANG M,YAN Y.The mechanism of 6,7,4'-trihydroxyisoflavones inhibiting cervical cancer immune escape by up-regulating MICA/B expression[J].Chinese Journal of Immunology,2021,37(23):2875-2879.
[10]TAE BS,JEON BJ,LEE YH,et al.Can natural killer cell activity help screen patients requiring a biopsy for the diagnosis of prostate cancer[J].Int Braz J Urol,2020,46(2):244-252.
[11]石涛,高艳,凡磊,等.H19靶向miR-130-5p调控自然杀伤细胞对前列腺癌细胞的杀伤作用[J].中国老年学杂志,2020,40(24):5254-5259.
SHI T,GAO Y,FAN L,et al.H19 targets miR-130-5p to regulate the killing effect of natural killer cells on prostate cancer cells [J].Chinese Journal of Gerontology,2020,40(24):5254-5259.
[12]ALI SYEDA Z,LANGDEN SSS,MUNKHZUL C,et al.Regulatory mechanism of microRNA expression in cancer[J].Int J Mol Sci,2020,21(5):1723-1740.
[13]NEVIANI P,WISE PM,MURTADHA M,et al.Natural killer-derived exosomal miR-186 inhibits neuroblastoma growth and immune escape mechanisms[J].Cancer Res,2019,79(6):1151-1164.
[14]OU ZL,LUO Z,WEI W,et al.Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells:role of circ_0000977/miR-153 axis[J].RNA Biol,2019,16(11):1592-1603.
[15]LI P,LUO X,XIE Y,et al.GC-derived EVs enriched with microRNA-675-3p contribute to the MAPK/PD-L1-mediated tumor immune escape by targeting CXXC4[J].Mol Ther Nucleic Acids,2020,22(1):615-626.
[16]谢淑华,沈娟,张燕楠,等.IL-12恢复化疗药物对人细胞免疫功能的抑制作用[J].免疫学杂志,2018,34(6):461-469.
XIE SH,SHEN J,ZHANG YN,et al.IL-12 restores the inhibitory effect of chemotherapeutic drugs on human cellular immune function [J].Journal of Immunology,2018,34(6):461-469.
[17]FANG P,XIANG L,CHEN W,et al.LncRNA GAS5 enhanced the killing effect of NK cell on liver cancer through regulating miR-544/RUNX3[J].Innate Immun,2019,25(2):99-109.
[18]SUN Q,ZHANG Y,LIU M,et al.Prognostic and diagnostic significance of galectins in pancreatic cancer:a systematic review and meta-analysis[J].Cancer Cell Int,2019,19(1):309-322.
[19]CHOU FC,CHEN HY,KUO CC,et al.Role of galectins in tumors and in clinical immunotherapy[J].Int J Mol Sci,2018,19(2):430-440.
[20]LIANG Z,WU B,JI Z,et al.The binding of LDN193189 to CD133 C-terminus suppresses the tumorigenesis and immune escape of liver tumor-initiating cells[J].Cancer Lett,2021,513(1):90-100.
[21]TIRABOSCHI C,GENTILINI L,VELAZQUEZ C,et al.Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome[J].J Immunother Cancer,2020,8(2):e001535.
[22]SHARMA S,CWIKLINSKI K,SYKES DE,et al.Use of glycoproteins-prostate-specific membrane antigen and galectin-3 as primary tumor markers and therapeutic targets in the management of metastatic prostate cancer[J].Cancers(Basel),2022,14(11):2704-2722.